1. Home
  2. CDMO vs REX Comparison

CDMO vs REX Comparison

Compare CDMO & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDMO
  • REX
  • Stock Information
  • Founded
  • CDMO 1981
  • REX 1980
  • Country
  • CDMO United States
  • REX United States
  • Employees
  • CDMO N/A
  • REX N/A
  • Industry
  • CDMO Biotechnology: Pharmaceutical Preparations
  • REX Major Chemicals
  • Sector
  • CDMO Health Care
  • REX Industrials
  • Exchange
  • CDMO Nasdaq
  • REX Nasdaq
  • Market Cap
  • CDMO 784.1M
  • REX 778.2M
  • IPO Year
  • CDMO N/A
  • REX N/A
  • Fundamental
  • Price
  • CDMO $12.15
  • REX $46.41
  • Analyst Decision
  • CDMO Buy
  • REX Strong Buy
  • Analyst Count
  • CDMO 5
  • REX 1
  • Target Price
  • CDMO $13.63
  • REX $60.00
  • AVG Volume (30 Days)
  • CDMO 3.6M
  • REX 92.2K
  • Earning Date
  • CDMO 12-05-2024
  • REX 11-29-2024
  • Dividend Yield
  • CDMO N/A
  • REX N/A
  • EPS Growth
  • CDMO N/A
  • REX 166.93
  • EPS
  • CDMO N/A
  • REX 3.92
  • Revenue
  • CDMO $142,358,000.00
  • REX $718,079,000.00
  • Revenue This Year
  • CDMO $19.31
  • REX N/A
  • Revenue Next Year
  • CDMO $21.14
  • REX $13.53
  • P/E Ratio
  • CDMO N/A
  • REX $11.84
  • Revenue Growth
  • CDMO N/A
  • REX N/A
  • 52 Week Low
  • CDMO $4.07
  • REX $35.73
  • 52 Week High
  • CDMO $12.48
  • REX $60.79
  • Technical
  • Relative Strength Index (RSI)
  • CDMO 67.73
  • REX 50.61
  • Support Level
  • CDMO $11.67
  • REX $47.81
  • Resistance Level
  • CDMO $12.30
  • REX $49.55
  • Average True Range (ATR)
  • CDMO 0.27
  • REX 1.51
  • MACD
  • CDMO 0.17
  • REX 0.00
  • Stochastic Oscillator
  • CDMO 89.03
  • REX 39.15

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

About REX REX American Resources Corporation

REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.

Share on Social Networks: